Did FDA’s Positive Reykjavik Plant Outcome Just Shift Alvotech’s (ALVO) Biosimilar Expansion Narrative?
Alvotech recently announced that the FDA closed its inspection of the company's Reykjavik facility with a Voluntary Action Indicated classification, addressing previous observations and allowing the advancement of multiple Biologics License Applications. This positive regulatory outcome reduces near-term overhang and supports the company's efforts …